Spyre Therapeutics SYRE
NASDAQ SYRE
$89.03 +4.31 (+5.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Total Current Liabilities (2015 - 2026)

Updated

Spyre Therapeutics' Total Current Liabilities came in at $63.3 million for Q2 2026, down 23.8% from $83.06 million a year earlier and down 25.7% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Total Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Spyre Therapeutics' Total Current Liabilities was $58.69 million, up 8.6% from FY2024.

  • Total Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 29.0% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $54.06 million in FY2024 (+69.1%), $31.98 million in FY2023 (+118.2%), $14.66 million in FY2022 (-27.2%) and $20.14 million in FY2021 (+22.5%).
  • The five-year range for quarterly Total Current Liabilities is $12.64 million (Q1 2023) to $232.23 million (Q2 2023).
  • Year-over-year, Total Current Liabilities increased in six of the last eight quarters, with growth averaging 52.9%.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q2 2025 (growth of 275.5%), and the weakest in Q2 2024 (a decline of 90.5%).
  • Business Quant data shows SYRE's Total Current Liabilities at $85.16 million (Q1 2026), $58.69 million (Q4 2025) and $46.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Spyre Therapeutics 7.46 Bn 7.46 Bn - 63.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.30 Mn
Mar 31, 2026 85.16 Mn
Dec 31, 2025 58.69 Mn
Sep 30, 2025 46.27 Mn
Jun 30, 2025 83.06 Mn
Mar 31, 2025 70.68 Mn
Dec 31, 2024 54.06 Mn
Sep 30, 2024 57.54 Mn
Jun 30, 2024 22.12 Mn
Mar 31, 2024 42.82 Mn
Dec 31, 2023 31.98 Mn
Sep 30, 2023 44.87 Mn
Jun 30, 2023 232.23 Mn
Mar 31, 2023 12.64 Mn
Dec 31, 2022 14.66 Mn
Sep 30, 2022 17.68 Mn
Jun 30, 2022 15.86 Mn
Mar 31, 2022 16.30 Mn
Dec 31, 2021 20.14 Mn
Sep 30, 2021 20.43 Mn
API Access

Spyre Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SYRE&period=max&api_key=YOUR_API_KEY